Follow Expert Insight, Commentary, and Intelligence On...

Latest Updates

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb) / Trazimera® (trastuzumab-qyyp) / Kanjinti® (trastuzumab-anns) / Hercessi™ (trastuzumab-strf) - July 2025

Trastuzumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs… more

July California Minimum Wage Increases

On January 1, 2025, California increased their state minimum wage to $16.50 per hour for all employers, regardless of size. While California may have one of the highest state-mandated minimum wages, voters rejected the November 2024… more

Securities are Securities

On July 9, 2025, Commissioner Hester Peirce, head of the SEC’s Crypto Task Force, in a published statement said, “Tokenized securities are still securities.” And, as such, the federal securities laws apply to transactions involving… more

Watch This